Serial 88319649
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 05 Jan 2026)
What this means for you
Registered since 15 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88319649
- Registration number
- 5882928
- Mark type
- Design / logo
- Filed
- 28 Feb 2019
- Published for opposition
- 30 Jul 2019
- Registered
- 15 Oct 2019
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical drug development services; testing of pharmaceuticals
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 05 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 15 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 30 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2019 — PUBLISHED FOR OPPOSITION
- 25 Jul 2019 — ASSIGNED TO EXAMINER
- 10 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED